These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 1278097

  • 41. Inhibitory actions of calmodulin antagonists on steroidogenesis in zona glomerulosa cells.
    Wilson JX, Aguilera G, Catt KJ.
    Endocrinology; 1984 Oct; 115(4):1357-63. PubMed ID: 6090099
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Inhibition of induced aldosterone biosynthesis with a specific antagonist of angiotensin II.
    Chiu AT, Peach MJ.
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):341-4. PubMed ID: 4360940
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Effects of adrenomedullin on the human adrenal glands: an in vitro study.
    Andreis PG, Neri G, Prayer-Galetti T, Rossi GP, Gottardo G, Malendowicz LK, Nussdorfer GG.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1167-70. PubMed ID: 9100590
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zone.
    Aguilera G, Harwood JP, Catt KJ.
    Nature; 1981 Jul 16; 292(5820):262-3. PubMed ID: 6114434
    [Abstract] [Full Text] [Related]

  • 49. Role of converting enzyme in the cardiovascular and adrenal cortical responses to (des-Asp1)-angiotensin I.
    Larner A, Vaughan ED, Tsai BS, Peach MJ.
    Proc Soc Exp Biol Med; 1976 Sep 16; 152(4):631-4. PubMed ID: 184474
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Obligatory Metabolism of Angiotensin II to Angiotensin III for Zona Glomerulosa Cell-Mediated Relaxations of Bovine Adrenal Cortical Arteries.
    Kopf PG, Park SK, Herrnreiter A, Krause C, Roques BP, Campbell WB.
    Endocrinology; 2018 Jan 01; 159(1):238-247. PubMed ID: 29088382
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effect of three angiotensin II antagonists, [Sar1, Thr8]-, [Sar1, Ile8]- and [Sar1, Ala8]angiotensin II on blood pressure and endocrine factors in normal subjects.
    Hata T, Ogihara T, Nakamaru M, Gotoh S, Masuo K, Saeki S, Kumagai A, Kumahara Y.
    Eur J Clin Pharmacol; 1982 Jan 01; 23(1):7-10. PubMed ID: 6751836
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Studies on cyclic nucleotides in the adrenal gland. VIII. Effects of angiotensin on adenosine 3',5'-monophosphate and steroidogenesis in the adrenal cortex.
    Shima S, Kawashima Y, Hirai M.
    Endocrinology; 1978 Oct 01; 103(4):1361-7. PubMed ID: 217676
    [Abstract] [Full Text] [Related]

  • 59. Action of (1-des(aspartic acid), 8-isoleucine) angiotensin II upon the pressor and steroidogenic activity of angiotensin II.
    Bravo EL, Khosla MC, Bumpus FM.
    J Clin Endocrinol Metab; 1975 Mar 01; 40(3):530-3. PubMed ID: 234979
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.